| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $135.2M | +18.2% |
| Cost of Revenue | $34.2M | +9.9% |
| Gross Profit | $101.0M | +21.4% |
| R&D Expense | $59.3M | +72.2% |
| SG&A Expense | $40.7M | +59.0% |
| Operating Income | -$71.8M | -201.3% |
| Pre-tax Income | -$70.6M | -190.9% |
| Income Tax | $186K | +129.6% |
| Net Income | -$70.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $203.2M | -20.4% |
| Accounts Receivable | $22.7M | +9.5% |
| Current Assets | $231.5M | -17.6% |
| Total Assets | $256.3M | -10.8% |
| Current Liabilities | $22.8M | +22.1% |
| Total Liabilities | $32.7M | +74.6% |
| Stockholders' Equity | $223.6M | -16.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.0M | -112.6% |
| Capital Expenditures | $4.4M | +40.9% |
| Investing Cash Flow | -$9.7M | -211.8% |
| Financing Cash Flow | $3.5M | -98.4% |
| Free Cash Flow | -$50.4M | -103.6% |
| -190.7% |
| EPS (Basic) | -$1.20 | -64.4% |
| EPS (Diluted) | -$1.20 | -64.4% |